What development phase is METHANTHELINE in?

METHANTHELINE is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

METHANTHELINE

FDA-approved approved Small molecule Quality 5/100

At a glance

Generic name	METHANTHELINE
Modality	Small molecule
Phase	FDA-approved
First approval	1951

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

METHANTHELINE CI brief — competitive landscape report
METHANTHELINE updates RSS · CI watch RSS